Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rett Syndrome, MECP2 Duplication Disorder, and Rett- Related Disorders Natural History Protocol

NCT02738281 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT02738281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02738281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rett Syndrome, MECP2 Duplication Disorder, and Rett- Related Disorders Natural History Protocol
Lead sponsor
University of Alabama at Birmingham
Phase
Observational
Overall status
Completed
Start date
November 30, 2015
Completion date
July 31, 2021
Enrollment
1,044 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

cdkl5 disorder, foxg1 syndrome, mecp2 duplication disorder, rett syndrome